These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32530086)

  • 21. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention and Treatment of Thrombotic and Hemorrhagic Complications in Patients Supported by Continuous-Flow Left Ventricular Assist Devices.
    Loyaga-Rendon RY; Jani M; Fermin D; McDermott JK; Vancamp D; Lee S
    Curr Heart Fail Rep; 2017 Dec; 14(6):465-477. PubMed ID: 29075955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Watchful Waiting in Continuous-Flow Left Ventricular Assist Device Patients With Ongoing Hemolysis Is Associated With an Increased Risk for Cerebrovascular Accident or Death.
    Levin AP; Saeed O; Willey JZ; Levin CJ; Fried JA; Patel SR; Sims DB; Nguyen JD; Shin JJ; Topkara VK; Colombo PC; Goldstein DJ; Naka Y; Takayama H; Uriel N; Jorde UP
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27166248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term discontinuation of antithrombotic therapy in patients with HeartMate II continuous-flow left ventricular assist device support.
    Schurr JW; Seifert FC; McLarty AJ
    Int J Artif Organs; 2019 Dec; 42(12):770-774. PubMed ID: 31298625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effect of Age on Outcomes After Destination-Therapy Left Ventricular Assist Device Implantation: An Analysis of the IMACS Registry.
    Aleksova N; Alba AC; Fan CS; Amin F; Kiamanesh O; McGuinty C; Lee H; Duero Posada JG; Ross HJ; Billia F; Rao V
    Can J Cardiol; 2021 Mar; 37(3):467-475. PubMed ID: 32585330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
    Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
    J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased cyclic guanosine monophosphate levels and continuous-flow left-ventricular assist devices: Implications for gastrointestinal bleeding.
    Grosman-Rimon L; Tumiati LC; Fuks A; Jacobs I; Lalonde SD; Cherney DZ; Rao V
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):219-27. PubMed ID: 26515873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thalidomide Use Reduces Risk of Refractory Gastrointestinal Bleeding in Patients with Continuous Flow Left Ventricular Assist Devices.
    Namdaran P; Zikos TA; Pan JY; Banerjee D
    ASAIO J; 2020 Jun; 66(6):645-651. PubMed ID: 31425265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Patients with Ventricular Assist Devices Presenting to an Urban Emergency Department.
    McKillip RP; Gopalsami A; Montoya M; Kim G; Walter JJ; Juricek C; Shappell E
    West J Emerg Med; 2018 Nov; 19(6):907-911. PubMed ID: 30429920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significantly higher rates of gastrointestinal bleeding and thromboembolic events with left ventricular assist devices.
    Shrode CW; Draper KV; Huang RJ; Kennedy JL; Godsey AC; Morrison CC; Shami VM; Wang AY; Kern JA; Bergin JD; Ailawadi G; Banerjee D; Gerson LB; Sauer BG
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1461-7. PubMed ID: 24480675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timing of Gastrointestinal Bleeding After Implantation of Left Ventricular Assist Devices Associates With Anatomic Location, Presentation, and Management.
    Tabibian JH; Rhoades DP; Forde KA; McLean RC; Chandrasekhara V
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):448-454. PubMed ID: 29906524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early signatures of bleeding and mortality in patients on left ventricular assist device support: novel methods for personalized risk-stratification.
    Shrout T; Sexton T; Vsevolozhskaya O; Guglin M; Shafii A; Smyth S
    Biomarkers; 2019 Jul; 24(5):448-456. PubMed ID: 31055944
    [No Abstract]   [Full Text] [Related]  

  • 33. A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report.
    Mehra MR; Uriel N; Naka Y; Cleveland JC; Yuzefpolskaya M; Salerno CT; Walsh MN; Milano CA; Patel CB; Hutchins SW; Ransom J; Ewald GA; Itoh A; Raval NY; Silvestry SC; Cogswell R; John R; Bhimaraj A; Bruckner BA; Lowes BD; Um JY; Jeevanandam V; Sayer G; Mangi AA; Molina EJ; Sheikh F; Aaronson K; Pagani FD; Cotts WG; Tatooles AJ; Babu A; Chomsky D; Katz JN; Tessmann PB; Dean D; Krishnamoorthy A; Chuang J; Topuria I; Sood P; Goldstein DJ;
    N Engl J Med; 2019 Apr; 380(17):1618-1627. PubMed ID: 30883052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and management of gastrointestinal bleeding with continuous flow assist devices.
    Aggarwal A; Pant R; Kumar S; Sharma P; Gallagher C; Tatooles AJ; Pappas PS; Bhat G
    Ann Thorac Surg; 2012 May; 93(5):1534-40. PubMed ID: 22541185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients.
    Whitson BA; Eckman P; Kamdar F; Lacey A; Shumway SJ; Liao KK; John R
    Ann Thorac Surg; 2014 Jun; 97(6):2097-103. PubMed ID: 24775803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased Rate of Pump Thrombosis and Cardioembolic Events Following Ventricular Tachycardia Ablation in Patients Supported With Left Ventricular Assist Devices.
    Grinstein J; Garan AR; Oesterle A; Fried J; Imamura T; Mai X; Kalantari S; Sayer G; Kim GH; Sarswat N; Raikhelkar J; Adatya S; Jeevanandam V; Flatley E; Moss J; Uriel N
    ASAIO J; 2020; 66(10):1127-1136. PubMed ID: 33136600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding Left Ventricular Assist Devices.
    Aissaoui N; Jouan J; Gourjault M; Diebold B; Ortuno S; Hamdan A; Latremouille C; Pirracchio R; Morshuis M
    Blood Purif; 2018; 46(4):292-300. PubMed ID: 30048974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and Treatment Algorithm for Blood Flow Obstructions in Patients With Left Ventricular Assist Device.
    Scandroglio AM; Kaufmann F; Pieri M; Kretzschmar A; Müller M; Pergantis P; Dreysse S; Falk V; Krabatsch T; Potapov EV
    J Am Coll Cardiol; 2016 Jun; 67(23):2758-2768. PubMed ID: 27282897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.